B Cell Production of Tumor Necrosis Factor in Response to Pneumocystis murina Infection in Mice

ABSTRACT Pneumocystis species are opportunistic fungal pathogens that induce tumor necrosis factor (TNF) production by alveolar macrophages. Here we report that B cells from the draining lymph nodes as well as lung CD4+ T cells are important producers of TNF upon Pneumocystis murina infection. To determine the importance of B cell-derived TNF in the primary response to P. murina, we generated bone marrow chimeras whose B cells were unable to produce TNF. The lung P. murina burden at 10 days postinfection in TNF knockout (TNFKO) chimeras was significantly higher than that in wild-type (WT) chimeras, which corresponded to reduced numbers of activated CD4+ T cells in the lungs at this early time point. Furthermore, CD4+ T cells isolated from P. murina-infected TNFKO chimeras were unable to stimulate clearance of P. murina upon adoptive transfer to recombinase-deficient (RAG1KO) hosts. Together, these data indicate that B cell-derived TNF plays an important function in promoting CD4+ T cell expansion and production of TNF and facilitating protection against P. murina infection.

[1]  A. Limper,et al.  Pneumocystis pneumonia in patients treated with rituximab. , 2013, Chest.

[2]  Huanhuan Li,et al.  TNF-α-Secreting B Cells Contribute to Myocardial Fibrosis in Dilated Cardiomyopathy , 2013, Journal of Clinical Immunology.

[3]  J. Browning,et al.  Regulation of TH2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells , 2012, Nature Immunology.

[4]  K. Tobinai,et al.  Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy , 2010, Leukemia & lymphoma.

[5]  Sudhir Gupta,et al.  TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors , 2010, Journal of Clinical Immunology.

[6]  Kim L Kusser,et al.  Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. , 2009, Immunity.

[7]  R. Ahmed,et al.  Requirement of B Cells for Generating CD4+ T Cell Memory1 , 2009, The Journal of Immunology.

[8]  Ravi S. Misra,et al.  B Cells Promote Resistance to Heterosubtypic Strains of Influenza via Multiple Mechanisms1 , 2008, The Journal of Immunology.

[9]  Laurie A. Minns,et al.  B Cells Amplify IFN-γ Production By T Cells via a TNF-α-Mediated Mechanism1 , 2007, The Journal of Immunology.

[10]  Melanie R Rutkowski,et al.  Type I Interferon Signaling and B Cells Maintain Hemopoiesis during Pneumocystis Infection of the Lung1 , 2007, The Journal of Immunology.

[11]  A. Akdoğan,et al.  Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab , 2007, Scandinavian journal of infectious diseases.

[12]  J. Sprent,et al.  Measurement of T and B Cell Turnover with Bromodeoxyuridine , 1996, Current protocols in immunology.

[13]  R. Takayanagi,et al.  Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease , 2007, Digestive Diseases and Sciences.

[14]  T. Randall,et al.  B Cells Are Required for Generation of Protective Effector and Memory CD4 Cells in Response to Pneumocystis Lung Infection , 2006, The Journal of Immunology.

[15]  A. Limper,et al.  Pneumocystis Cell Wall β-Glucans Stimulate Alveolar Epithelial Cell Chemokine Generation through Nuclear Factor-κB–Dependent Mechanisms , 2005 .

[16]  J. Colombel,et al.  Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease. , 2005, Inflammatory bowel diseases.

[17]  T. Giese,et al.  IL-12p70-Dependent Th1 Induction by Human B Cells Requires Combined Activation with CD40 Ligand and CpG DNA 1 , 2004, The Journal of Immunology.

[18]  A. Antinori,et al.  Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-α by human macrophages , 2004, Medical Microbiology and Immunology.

[19]  T. Randall,et al.  Clearance of Pneumocystis carinii in Mice Is Dependent on B Cells But Not on P. carinii-Specific Antibody 1 , 2003, The Journal of Immunology.

[20]  A. Chervonsky,et al.  Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. , 2002, Immunity.

[21]  J. Cyster,et al.  Splenic T Zone Development Is B Cell Dependent , 2001, The Journal of experimental medicine.

[22]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[23]  J. Shellito,et al.  Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii. , 2000, The Journal of infectious diseases.

[24]  H. Vordermeier,et al.  The role of B cells in the establishment of T cell response in mice infected with an intracellular bacteria, Listeria monocytogenes. , 1999, Cellular immunology.

[25]  A. Limper,et al.  Alveolar macrophage interactions with Pneumocystis carinii. , 1999, The Journal of laboratory and clinical medicine.

[26]  S. Constant B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. , 1999, Journal of immunology.

[27]  D. Kachel,et al.  Gamma Interferon Stimulates Rat Alveolar Macrophages To Kill Pneumocystis carinii byl-Arginine- and Tumor Necrosis Factor-Dependent Mechanisms , 1999, Infection and Immunity.

[28]  R. Brunham,et al.  Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. , 1998, Journal of immunology.

[29]  M. Moore,et al.  Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-gamma and type 1 and 2 TNF receptor genes. , 1998, Journal of immunology.

[30]  B. Garvy,et al.  CONTENT ALERTS , 1997 .

[31]  B. Garvy,et al.  Neutralization of interferon-gamma exacerbates pneumocystis-driven interstitial pneumonitis after bone marrow transplantation in mice. , 1997, The Journal of clinical investigation.

[32]  B. Garvy,et al.  Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection , 1997, Infection and immunity.

[33]  H. Marcotte,et al.  Pneumocystis carinii infection in transgenic B cell-deficient mice. , 1996, The Journal of infectious diseases.

[34]  V. Maino,et al.  Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.

[35]  J. West,et al.  B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. , 1995, Journal of immunology.

[36]  J. Standing,et al.  Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. , 1993, Journal of immunology.

[37]  C. Sidman,et al.  Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice , 1993, Infection and immunity.

[38]  J. Shellito,et al.  Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. , 1993, American journal of respiratory cell and molecular biology.

[39]  A. Harmsen,et al.  Resolution of Pneumocystis carinii pneumonia in CD4+ lymphocyte- depleted mice given aerosols of heat-treated Escherichia coli , 1992, The Journal of experimental medicine.

[40]  C. Sidman,et al.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. , 1992, The Journal of clinical investigation.

[41]  E. A. Havell,et al.  Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection , 1992, Infection and immunity.

[42]  P. Carayon,et al.  Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. , 1992, Journal of immunological methods.

[43]  H. D. Liggitt,et al.  Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon , 1991, Infection and immunity.

[44]  D. Gray,et al.  Novel pathways of antigen presentation for the maintenance of memory. , 1991, International immunology.

[45]  A. Harmsen,et al.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice , 1990, The Journal of experimental medicine.

[46]  D. Mitchell,et al.  Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor‐alpha production in Pneumocystis carinii pneumonia , 1990, Clinical and experimental immunology.

[47]  D. L. Coleman,et al.  Pneumocystis carinii pneumonia in homosexual men. , 1982, AJR. American journal of roentgenology.

[48]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.